Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world transfusion independence among newly diagnosed acute myeloid leukaemia patients receiving venetoclax combinations versus other therapies
    Meeting Abstract

    Wolach, O.; Garcia, J.; Vachhani, P.; Zeidner, J.; Lai, C.; Moshe, Y.; Xavier, M.; Lee, S.; Zuckerman, T.; Pollyea, D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib monotherapy in patients with relapsed/refractory B-cell malignancies intolerant to prior covalent BTK inhibitor
    Meeting Abstract

    Munir, T.; Shah, N. N.; Wang, M.; Brown, J. R.; Patel, K.; Woyach, J.; Wierda, W. G.; Ujjani, C. S.; Eyre, T. A.; Zinzani, P. L.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia
    Journal Article

    Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
    NEJM Evidence (2023)

    Fulltext@MSK | Save
  • Development of a p-hydroxybenzyl-alcohol-linked glutamate prodrug for activation by pseudomonas carboxypeptidase G2
    Journal Article

    Lee, J. P.; Corless, B. C.; Gardner, T. J.; Scheinberg, D. A.; Tan, D. S.
    Organic Letters (2023)

    Fulltext@MSK | Save
  • Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: A review
    Review

    Locatelli, F.; Shah, B.; Thomas, T.; Velasco, K.; Adedokun, B.; Aldoss, I.; Gore, L.; Hoelzer, D.; Bassan, R.; Park, J. H.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
    Journal Article

    Mun, S. S.; Meyerberg, J.; Peraro, L.; Korontsvit, T.; Gardner, T.; Malviya, M.; Kyi, C.; O’Cearbhaill, R. E.; Liu, C.; Dao, T.; more...
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
    Journal Article

    Molvi, Z.; Klatt, M. G.; Dao, T.; Urraca, J.; Scheinberg, D. A.; O'Reilly, R. J.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Characteristics and prognostic impact of IDH mutations in AML: A COG, SWOG, and ECOG analysis
    Journal Article

    Zarnegar-Lumley, S.; Alonzo, T. A.; Gerbing, R. B.; Othus, M.; Sun, Z.; Ries, R. E.; Wang, J.; Leonti, A.; Kutny, M. A.; Ostronoff, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis
    Journal Article

    Gupta, V.; Mascarenhas, J.; Kremyanskaya, M.; Rampal, R. K.; Talpaz, M.; Kiladjian, J. J.; Vannucchi, A. M.; Verstovsek, S.; Colak, G.; Dey, D.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib after a covalent BTK inhibitor in chronic lymphocytic leukemia
    Journal Article

    Mato, A. R.; Woyach, J. A.; Brown, J. R.; Ghia, P.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save